Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05285618 · ClinicalTrials.gov registry record · NA
The Perceptual Experience of Argus II Users
A NA study, sponsored by University of California, Santa Barbara.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT05285618 is a NA study that has completed, run by University of California, Santa Barbara. The registered enrollment target is 6 participants.
The verdict
NCT05285618, a NA study, has completed, sponsored by University of California, Santa Barbara.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
This Basic Experimental Studies Involving Humans (BESH) study investigates phosphene perception and performance factors in blind participants implanted with the Argus II retinal prosthesis system. Using paired-electrode stimulation, we analyze how phosphene shape and number are influenced by neuroanatomical factors, stimulus parameters, and spatial offsets. Additionally, we examine the causes of high current thresholds and limited spatial resolution, which impede pattern vision in Argus II devices. This research aims to provide insights for optimizing stimulation strategies and improving retinal prosthesis design.
Interventions
- DEVICE Argus II
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2022-01-11 |
| Est. Completion | 2023-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05285618
The ClinicalTrials.gov registry entry for NCT05285618 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Santa Barbara, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Argus II is the first listed.
NCT05285618 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05285618 about?
NCT05285618 is a clinical study titled "The Perceptual Experience of Argus II Users". This Basic Experimental Studies Involving Humans (BESH) study investigates phosphene perception and performance factors in blind participants implanted with the Argus II retinal prosthesis system. Using paired-electrode stimulation, we analyze how phosphene shape and number are influenced by neuroan...
What is the current status of trial NCT05285618?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2022-01-11. Estimated completion is 2023-08-31.
What interventions are being tested in trial NCT05285618?
The interventions under investigation include: Argus II (DEVICE).
Who is sponsoring clinical trial NCT05285618?
This trial is sponsored by University of California, Santa Barbara, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.